Physicians' Academy for Cardiovascular Education

Vascular calcification in kidney disease: Epigenetics as a novel approach?

Meeting report with presentation slides and video of a PACE-CME symposium held during ERA-EDTA 2019 in Budapest, Hungary on the potential role of epigenetics in CKD

The role of ALP as predictor of CV events and vascular calcification in CKD

10' education - June 15, 2019 - Dr. Mathias Haarhaus, MD
Alkaline phosphatase (ALP) is a potential novel treatment target for CVD in CKD. Dr. Haarhaus discusses ALP-related mechanisms of increased CV risk and beneficial effects of the BET inhibitor apabetalone.

Alkaline phosphatase (ALP) is a potential novel treatment target for CVD in CKD. Dr. Haarhaus discusses ALP-related mechanisms of increased CV risk and beneficial effects of the BET inhibitor apabetalone.

Epigenetic mechanisms targeting ALP: A pathway for prevention of vascular calcification?

10' education - Aug. 7, 2019 - Marta Ruiz-Ortega, PhD
Epigenetic processes are involved in renal damage. Marta Ruiz-Ortega describes the role of vascular calcification and alkaline phosphatase (ALP) in CKD and effects of BET inhibition on vascular calcification.

Epigenetic processes are involved in renal damage. Marta Ruiz-Ortega describes the role of vascular calcification and alkaline phosphatase (ALP) in CKD and effects of BET inhibition on vascular calcification.

Slides: Targeting residual cardiovascular risk & vascular calcification: The clinical perspective for BET inhibition

Slides (presentation) - July 3, 2019 - Vincent Brandenburg, MD - Würselen, Germany - CME symposium held during ERA EDTA 2019
This lecture by prof. Vincent Brandenburg was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: The role of ALP as predictor of cardiovascular events and vascular calcification in CKD

Slides (presentation) - July 3, 2019 - Mathias Haarhaus, MD – Stockholm, Sweden - CME symposium held during ERA EDTA 2019
This lecture by dr. Mathias Haarhaus was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Slides: Epigenetic mechanisms targeting ALP: A pathway for prevention?

Slides (presentation) - July 3, 2019 - Marta Ruiz-Ortega, PhD – Madrid, Spain - CME symposium held during ERA EDTA 2019
This lecture by prof. Marta Ruiz-Ortega was part of a CME-accredited symposium

Slides as educational service to PACE members and meeting participants

Targeting residual cardiovascular risk & vascular calcification: The clinical perspective for BET inhibition

10' education - July 3, 2019 - ERA-EDTA 2019 - Vincent Brandenburg, MD
Epigenetics contribute to vascular calcification, which is a hallmark of CVD in CKD. Prof. Brandenburg explains how BET inhibition can interfere with factors and pathways associated with vascular calcification.

ERA-EDTA 2019 Epigenetics contribute to vascular calcification, which is a hallmark of CVD in CKD. Prof. Brandenburg explains how BET inhibition can interfere with factors and pathways associated with vascular calcification.

Vascular calcification in kidney disease: Epigenetics as a novel approach?
Vascular calcification in kidney disease: Epigenetics as a novel approach?